TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CGON

CG Oncology, Inc.

Healthcare · Biotechnology

67.20$ -2.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGON
Line item 2021 2022 2023 2024 2025
– +151.7% +34.9% +278.7% +4.9%
– +152.0% +31.9% +288.5% +0.7%
– +64.4% -90.6% +3,009.9% -87.4%
– +167.7% +30.8% +295.4% +0.0%
– +15,050.0% -69.6% +748.9% -11.9%
– – – – –
– – – – –
– – – – –
– +22.4% -35.7% +47.6% +82.0%
– +158.2% -7.6% +49.9% +44.3%
– +203.6% -91.4% -76.3% +391.9%
– -1.8% +229.1% +101.0% -12.3%
– -45.9% – – –
– +211.0% +47.6% +296.9% +2.6%
– – – – –
– +0.0% +0.0% -6.2% +23.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?